| Mrs Poornima Anil Panjwani, PA-C | |
|
329 Remington Blvd Ste 205, Bolingbrook, IL 60440-5817 | |
| (630) 226-1130 | |
| Not Available |
| Full Name | Mrs Poornima Anil Panjwani |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 16 Years |
| Location | 329 Remington Blvd Ste 205, Bolingbrook, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932335627 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 085003291 (Illinois) | Secondary |
| 363AM0700X | Physician Assistant - Medical | 085.003291 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gateway Spine And Pain Physicians Llc | 6507941598 | 4 |
News Archive
The New York Times examines grassroots HIV/AIDS outreach and testing efforts aimed at gay men in China. The newspaper highlights "Lingnan Health Center, an organization run largely by gay volunteers," and recounts the story of Le, "a gay man who would give only his first name."
The PATH Malaria Vaccine Initiative (MVI) today announced a new collaboration to initiate development toward a vaccine that may eventually help eliminate and eradicate malaria. This collaboration with the Johns Hopkins Bloomberg School of Public Health (JHSPH) and the Sabin Vaccine Institute (Sabin) marks MVI's first investment in transmission-blocking vaccines (TBVs). This vaccine approach aims to stop the malaria parasite from developing in the mosquito, effectively blocking transmission of malaria from mosquitoes to humans. Malaria kills nearly 900,000 people per year, most of them children younger than age five.
Chemical Engineers in Switzerland have created a plastic film that's up to 1000 times more effective at killing E. coli bacteria cells than conventional methods.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing innovative proprietary drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfunction and conducting clinical trials on its three lead drugs (Ampion, Optina & Zertane), announced the significant results from their further analysis of its Optina trial on DME.
Wearers of cochlear implants and hearing aids often have difficulty teasing out what someone is saying over "babble" - the cacophony of other talkers - and other ambient sounds. New York University researchers have devised a novel solution: an algorithmic approach that, like making drinkable water from pond water, distills the talker's voice from a turbid wash of noise.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Poornima Anil Panjwani, PA-C 329 Remington Blvd Ste 205, Bolingbrook, IL 60440-5817 Ph: (503) 862-6382 | Mrs Poornima Anil Panjwani, PA-C 329 Remington Blvd Ste 205, Bolingbrook, IL 60440-5817 Ph: (630) 226-1130 |
News Archive
The New York Times examines grassroots HIV/AIDS outreach and testing efforts aimed at gay men in China. The newspaper highlights "Lingnan Health Center, an organization run largely by gay volunteers," and recounts the story of Le, "a gay man who would give only his first name."
The PATH Malaria Vaccine Initiative (MVI) today announced a new collaboration to initiate development toward a vaccine that may eventually help eliminate and eradicate malaria. This collaboration with the Johns Hopkins Bloomberg School of Public Health (JHSPH) and the Sabin Vaccine Institute (Sabin) marks MVI's first investment in transmission-blocking vaccines (TBVs). This vaccine approach aims to stop the malaria parasite from developing in the mosquito, effectively blocking transmission of malaria from mosquitoes to humans. Malaria kills nearly 900,000 people per year, most of them children younger than age five.
Chemical Engineers in Switzerland have created a plastic film that's up to 1000 times more effective at killing E. coli bacteria cells than conventional methods.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing innovative proprietary drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfunction and conducting clinical trials on its three lead drugs (Ampion, Optina & Zertane), announced the significant results from their further analysis of its Optina trial on DME.
Wearers of cochlear implants and hearing aids often have difficulty teasing out what someone is saying over "babble" - the cacophony of other talkers - and other ambient sounds. New York University researchers have devised a novel solution: an algorithmic approach that, like making drinkable water from pond water, distills the talker's voice from a turbid wash of noise.
› Verified 5 days ago